Chinese HCC Efficacy Evaluation, Response and Safety Study of TareSphere
Clinical trial NCT06900543 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06900543
- Sponsor
- Chengdu New Radiomedicine Technology Co. LTD.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-04-15
- Primary completion
- 2027-10-01
- Enrollment
- 108
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.